Page 4 - மையம் மருத்துவமனையாளர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மையம் மருத்துவமனையாளர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மையம் மருத்துவமனையாளர் Today - Breaking & Trending Today

Genomic Test Helps Guide Precision Medicine to Estimate Risk of Prostate Cancer Metastasis, Death


Genomic Test Helps Guide Precision Medicine to Estimate Risk of Prostate Cancer Metastasis, Death
February 11, 2021
San Francisco, CA (UroToday.com)  A commercially available genomic test may help oncologists better determine which patients with recurrent prostate cancer may benefit from hormone therapy, according to new research from the Johns Hopkins Kimmel Cancer Center and 15 other medical centers.
Researchers studied prostate cancer samples from 352 participants in the NRG/RTOG 9601 clinical trial, which compared radiation therapy alone with radiation therapy combined with hormone therapy. The investigators found that the Decipher test, which measures the activity of 22 genes among seven known cancer pathways, independently estimated the participants’ risk of metastasis, death from prostate cancer, and overall survival. Researchers say it also guided treatment recommendations for recurrence of prostate cancer after surgery, helping identify patients most li ....

United States , University Of California San Francisco Medical Center , British Columbia , Thomas Jefferson University Hospital , San Diego , City Of , United Kingdom , San Francisco , Los Angeles , Natsar Pharm , Astellas Pharm , Phuoc Tran , Johns Hopkins University , National Cancer Institute , Data Management Center , Centre Hospitalier , University Of Michigan , Johns Hopkins Kimmel Cancer Center , University Of Chicago , York Cancer Center , Sinai Medical Center , College Of Wisconsin , University Of Miami Miller School Medicine , University College , Wellspan Health , Dana Farber Harvard Cancer Center ,

Botched Enrollment Seen as Ruining Big Xarelto Trial


email article
The failure of low-dose rivaroxaban (Xarelto) in the international COMMANDER-HF trial was traced back to aberrant patient recruiting practices and poor medication adherence in the largest enrolling region, one group found.
Study participants in Eastern Europe were unusually young and less likely to have coronary interventions and cardiac devices at enrollment. They also tended to have better renal function, lower plasma concentrations of BNP or NT-proBNP, and higher left ventricular ejection fraction, according to researchers led by João Pedro Ferreira, MD, PhD, of Centre Hospitalier Régional Universitaire de Nancy, Hopitaux de Brabois, France.
Moreover, the Eastern Europe subgroup had a uniquely low incidence of the primary endpoint (combined MI, stroke, or all-cause death) over the course of the trial: ....

United States , South Africa , Tufts Medical Center , Pedro Ferreira , Nicole Lou , Marvin Konstam , Centre Hospitalier , Eastern Europe , Universitaire De Nancy , Hopitaux De Brabois , Western Europe , North America , Latin America , Medpage Today , ஒன்றுபட்டது மாநிலங்களில் , டஃப்ட்ஸ் மருத்துவ மையம் , பேடரோ ஃபெரீரா , நிக்கோல் லூ , மையம் மருத்துவமனையாளர் , கிழக்கு யூரோப் , யுனிவர்சிட்டேர் டி நான்சி , மேற்கு யூரோப் , வடக்கு அமெரிக்கா , லத்தீன் அமெரிக்கா ,

Promising tissue valve Tech Blocks the build-up of calcium


Promising tissue valve Tech Blocks the build-up of calcium
News Highlights: Promising tissue valve Tech Blocks the build-up of calcium
According to the COMMENCE researchers, a tissue valve built for less valve structural deterioration showed favorable safety and hemodynamic performance after 5 years of surgical aortic valve replacement (SAVR).
Surgical valves mounted with Resilia (a patented bovine pericardial tissue, from Edwards Lifesciences, formulated to reduce the calcification that often leads to valve dysfunction) have been associated with ‘quite satisfactory’ safety in 471 patients with a 30-day mortality and stroke rates of 1.2% and 1.6%, respectively, reported Joseph Bavaria, MD, of the University of Pennsylvania Hospital in Philadelphia. ....

New York , United States , University Of Pennsylvania Hospital , Nicole Lou , Gilbert Tang , Jessica Forcillo , Edwards Lifesciences , Center Hospitalier , Society Of Thoracic Surgeons , York Heart Association Class , Mount Sinai Health System , News Highlights , Tech Blocks , Joseph Bavaria , Pennsylvania Hospital , Thoracic Surgeons , New York City , Magna Ease , Medpage Today , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் பென்சில்வேனியா மருத்துவமனை , நிக்கோல் லூ , கில்பர்ட் டாங் , எட்வர்ட்ஸ் ஆயுள் அறிவியல் , மையம் மருத்துவமனையாளர் ,